Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19
Phase 2
Terminated
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- ViralClear Pharmaceuticals, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT04410354
- Locations
- 🇺🇸
Holy Cross Hospital, Fort Lauderdale, Florida, United States
🇺🇸HCA Houston Healthcare Medical Center, Houston, Texas, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath